HARRIS, Daniel. SGLT2 Inhibitors: A Novel Therapeutic Class for Diabetes Management. Cell Nature Science, [S. l.], v. 1, n. 1, 2025. Disponível em: https://cnsjournals.com/index.php/cns/article/view/4. Acesso em: 23 oct. 2025.